A Brazilian study has shown that a medication currently used for Hepatitis C can help fight the Zika virus. According to the research, the antiviral Sofosbuvir inhibits virus replication. The group of Brazilian researchers has published their findings today, in the scientific journal Scientific Reports.
The study was conducted by scientists from Oswaldo Cruz Foundation and the Federal University of Rio de Janeiro.
According to Thiago Moreno, the head of the team, both the Zika and the Hepatitis C viruses have a common protein: RNA polymerase. Sofosbuvir inhibits the protein, preventing the Hepatitis C virus from replicating. “Indeed, we found that Sofosbuvir has the same effects with the Zika virus,” the researchers said.